Status:
ACTIVE_NOT_RECRUITING
Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital
Lead Sponsor:
KK Women's and Children's Hospital
Collaborating Sponsors:
Renew Group
Conditions:
Vital Sign
Heart Rate
Eligibility:
FEMALE
21-70 years
Phase:
NA
Brief Summary
This proposal describes the evaluation of a CE-marked, FDA cleared vital signs Surveillance Monitoring system within an adult in-patient setting KK Women's and Children's Hospital ("KKH"), the main te...
Detailed Description
RENEW's Surveillance Monitoring system is made up of two main components: a patient-worn wireless vital signs monitor (Aingeal) that transmits data over Wi-Fi to a central station software platform (S...
Eligibility Criteria
Inclusion
- Adult female patients, aged 21 years or over
- Patients admitted to post-operative gynaecological ward at KKH Women's and Children's Hospital, Singapore
- Patients receiving opioid therapy via patient controlled analgesia (PCA)
- Patients that are on electronic nursing charting
- Patients that are on acute pain service monitoring
Exclusion
- Patients with active, implantable devices (such as a pacemaker or ICD)
- Patients with any skin condition or injury affecting the electrode placement site
- Patients that are pregnant (Heart Rate detection algorithm has not been designed to reject foetal heart rate)
Key Trial Info
Start Date :
January 31 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT03750318
Start Date
January 31 2019
End Date
December 31 2025
Last Update
October 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KK Women's and Children's Hospital
Singapore, Singapore, 229899